Lykos

MDMA assisted therapy for PTSD

Human 3 criteria:

Distribution shifting

Prior evidence of human use

Step change

Lykos is developing MDMA Assisted Therapy as a treatment for PTSD. Lykos is the for-profit spinout of the legendary non-profit MAPS, who is largely responsible for reintroducing the concept of Psychedelics as a therapeutic tool to the post-war-on-drugs world.

Under the radar for now - more info soon.

2022

XEIA invests

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! You've been added to our mailing list.
Oops! Something went wrong while submitting the form.
X-disciplinary Exploration, Investment & Acceleration

© 2025 XEIA Venture Partners, LLC